|
Age, y
|
0.855
|
NA
|
NA
|
0.976
|
NA
|
NA
|
|
Gender, male/female
|
0.852
|
NA
|
NA
|
0.572
|
NA
|
NA
|
|
a-Fetoprotein >400 vs. ≤ 200 ng/dL
|
0.209
|
NA
|
NA
|
0.064
|
NA
|
NA
|
|
Tumor size, >5 vs. ≤ 5 cm
|
0.005
|
1.699(1.203-2.685)
|
0.038
|
0.016
|
1.478(0.856-2.554)
|
0.161
|
|
Encapsulation complete vs. none
|
0.735
|
NA
|
NA
|
0.942
|
NA
|
NA
|
|
Tumor differentiation, III–IV vs. I–II
|
0.026
|
1.217(0.715-2.072)
|
0.468
|
0.015
|
1.157(1.103-2.584)
|
0.026
|
|
BCLC stage, C vs. B vs. A
|
0.003
|
1.783(1.265-2.564)
|
0.027
|
0.003
|
1.768(0.949-3.295)
|
0.073
|
|
Recurrence, yes vs. no
|
0.062
|
NA
|
NA
|
0.052
|
NA
|
NA
|
|
Peritumoral HMGB1, high vs. low
|
0.001
|
1.872(1.148-3.053)
|
0.009
|
0.002
|
1.697(1.035-2.783)
|
0.014
|
|
Intratumoral HMGB1, high vs. low
|
0.028
|
1.270(0.745-2.166)
|
0.462
|
0.060
|
NA
|
NA
|
|
Peritumoral CD68, high vs. low
|
0.017
|
1.567(1.058-2.563)
|
0.039
|
0.026
|
1.532(1.127-2.531)
|
0.037
|
|
Intratumoral CD68, high vs. low
|
0.952
|
NA
|
NA
|
0.823
|
NA
|
NA
|
